A citation-based method for searching scientific literature


List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
359
50


Continuous glucose monitoring and intensive treatment of type 1 diabetes.
William V Tamborlane, Roy W Beck, Bruce W Bode, Bruce Buckingham, H Peter Chase, Robert Clemons, Rosanna Fiallo-Scharer, Larry A Fox, Lisa K Gilliam, Irl B Hirsch,[...]. N Engl J Med 2008
929
50

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
Roy W Beck, Tonya D Riddlesworth, Katrina Ruedy, Andrew Ahmann, Stacie Haller, Davida Kruger, Janet B McGill, William Polonsky, David Price, Stephen Aronoff,[...]. Ann Intern Med 2017
158
40

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Marcus Lind, William Polonsky, Irl B Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist, Erik Schwarz, Arndís Finna Ólafsdóttir, Anders Frid, Hans Wedel,[...]. JAMA 2017
263
40

Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes.
Anders L Carlson, Deborah M Mullen, Richard M Bergenstal. Diabetes Technol Ther 2017
56
40

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System.
Timothy Bailey, Bruce W Bode, Mark P Christiansen, Leslie J Klaff, Shridhara Alva. Diabetes Technol Ther 2015
302
40

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
589
40

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.
Thomas Haak, Hélène Hanaire, Ramzi Ajjan, Norbert Hermanns, Jean-Pierre Riveline, Gerry Rayman. Diabetes Ther 2017
69
30




Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
Cornelis A J van Beers, J Hans DeVries, Susanne J Kleijer, Mark M Smits, Petronella H Geelhoed-Duijvestijn, Mark H H Kramer, Michaela Diamant, Frank J Snoek, Erik H Serné. Lancet Diabetes Endocrinol 2016
151
30

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
404
30

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.
Grazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, Davida F Kruger, Anne L Peters, Irl Hirsch, Richard M Bergenstal, Elena Toschi, Andrew J Ahmann, Viral N Shah,[...]. Diabetes Care 2017
123
30

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan,[...]. Diabetes Care 2018
144
30

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
604
30

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
20

Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.
Lorena Alarcon-Casas Wright, Irl B Hirsch. Diabetes Technol Ther 2017
71
20

Hypoglycemia: The neglected complication.
Sanjay Kalra, Jagat Jyoti Mukherjee, Subramanium Venkataraman, Ganapathi Bantwal, Shehla Shaikh, Banshi Saboo, Ashok Kumar Das, Ambady Ramachandran. Indian J Endocrinol Metab 2013
84
20


Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.
Anne L Peters, Andrew J Ahmann, Tadej Battelino, Alison Evert, Irl B Hirsch, M Hassan Murad, William E Winter, Howard Wolpert. J Clin Endocrinol Metab 2016
97
20




AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.
Timothy S Bailey, George Grunberger, Bruce W Bode, Yehuda Handelsman, Irl B Hirsch, Lois Jovanovič, Victor Lawrence Roberts, David Rodbard, William V Tamborlane, John Walsh. Endocr Pract 2016
70
20

The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.
Nicole M Ehrhardt, Mary Chellappa, M Susan Walker, Stephanie J Fonda, Robert A Vigersky. J Diabetes Sci Technol 2011
70
20

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).
Richard M Bergenstal, Andrew J Ahmann, Timothy Bailey, Roy W Beck, Joan Bissen, Bruce Buckingham, Larry Deeb, Robert H Dolin, Satish K Garg, Robin Goland,[...]. Diabetes Technol Ther 2013
148
20

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
140
20


Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
199
20

Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes.
Victoria Tyndall, Roland H Stimson, Nicola N Zammitt, Stuart A Ritchie, John A McKnight, Anna R Dover, Fraser W Gibb. Diabetologia 2019
47
20

Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial.
Othmar Moser, Max L Eckstein, Olivia McCarthy, Rachel Deere, Jason Pitt, David M Williams, Jennifer Hayes, Harald Sourij, Stephen C Bain, Richard M Bracken. Diabetes Obes Metab 2019
31
20

Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control.
Elizabeth Downie, Maria E Craig, Stephen Hing, Janine Cusumano, Albert K F Chan, Kim C Donaghue. Diabetes Care 2011
85
10

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
John M Lachin, Ionut Bebu, Richard M Bergenstal, Rodica Pop-Busui, F John Service, Bernard Zinman, David M Nathan. Diabetes Care 2017
78
10

Molecular mechanisms of diabetic kidney disease.
Kimberly Reidy, Hyun Mi Kang, Thomas Hostetter, Katalin Susztak. J Clin Invest 2014
355
10

Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes.
Eric S Kilpatrick, Alan S Rigby, Stephen L Atkin. Diabetes Care 2009
94
10

Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A(1c).
Takashi Uzu, Tsuguru Hatta, Naoko Deji, Tamani Izumiya, Hisami Ueda, Itsuko Miyazawa, Masami Kanasaki, Keiji Isshiki, Toshiji Nishio, Tetsuro Arimura. Ther Apher Dial 2009
35
10

Diabetic kidney disease.
Merlin C Thomas, Michael Brownlee, Katalin Susztak, Kumar Sharma, Karin A M Jandeleit-Dahm, Sophia Zoungas, Peter Rossing, Per-Henrik Groop, Mark E Cooper. Nat Rev Dis Primers 2015
170
10

Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.
Yeh-Wen Chu, Hsuan-Ming Lin, Jhi-Joung Wang, Shih-Feng Weng, Chih-Ching Lin, Chih-Chiang Chien. PLoS One 2017
14
10

6. Glycemic Targets.
. Diabetes Care 2017
212
10

Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study.
Joni Ricks, Miklos Z Molnar, Csaba P Kovesdy, Anuja Shah, Allen R Nissenson, Mark Williams, Kamyar Kalantar-Zadeh. Diabetes 2012
106
10

HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.
Giuseppe Penno, Anna Solini, Enzo Bonora, Cecilia Fondelli, Emanuela Orsi, Gianpaolo Zerbini, Susanna Morano, Franco Cavalot, Olga Lamacchia, Luigi Laviola,[...]. Diabetes Care 2013
87
10

Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Masaaki Inaba, Senji Okuno, Yasuro Kumeda, Shinsuke Yamada, Yasuo Imanishi, Tsutomu Tabata, Mikio Okamura, Shigeki Okada, Tomoyuki Yamakawa, Eiji Ishimura,[...]. J Am Soc Nephrol 2007
320
10

Haemodialysis-induced hypoglycaemia and glycaemic disarrays.
Masanori Abe, Kamyar Kalantar-Zadeh. Nat Rev Nephrol 2015
56
10

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
693
10


Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes.
Antonio Ceriello, Anna Novials, Emilio Ortega, Lucia La Sala, Gemma Pujadas, Roberto Testa, Anna Rita Bonfigli, Katherine Esposito, Dario Giugliano. Diabetes 2012
92
10

Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
Cheng-Chieh Lin, Ching-Chu Chen, Fei-Na Chen, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Sing-Yu Yang, Cheng-Chun Lee, Tsai-Chung Li. Am J Med 2013
41
10

Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.
Elizabeth Selvin, Andreea M Rawlings, Morgan Grams, Ronald Klein, Michael Steffes, Josef Coresh. Clin Chem 2014
41
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.